SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling

Molecular and Cellular Biology

Volumn 20, Issue 23, 2000, Pages 9018-9027

  Blake, R A ^a   Broome, M A ^a   Liu, X ^a   Wu, J ^a   Gishizky, M ^a   Sun, L ^a   Courtneidge, S A ^a  

^a SUGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 2,3 DIHYDRO 1H INDOLE 5 SULFONIC ACID AMIDE; 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 2,3 DIHYDRO 1H INDOLE 5 SULFONIC ACID DEMETHYLAMIDE; 2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; ADAPTOR PROTEIN; GROWTH FACTOR; PHOSPHOLIPASE C; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; SU 6657; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHEMICAL STRUCTURE; DNA SYNTHESIS INHIBITION; ENZYME INHIBITION; ENZYME SUBSTRATE; FIBROBLAST; GENE EXPRESSION; GENE INDUCTION; MOLECULAR PROBE; MUTAGENESIS; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; GENE EXPRESSION REGULATION; INDOLES; INHIBITORY CONCENTRATION 50; ISOENZYMES; MICE; MITOSIS; PLATELET-DERIVED GROWTH FACTOR; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-CBL; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; SULFONAMIDES; UBIQUITIN-PROTEIN LIGASES;

ANIMALIA;

EID: 0034458943     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.23.9018-9027.2000     Document Type: Article

References (35)

1. Myc but not Fos rescue of PDGF signalling block caused by kinase inactive Src
2. Src promotes PKCdelta degradation
3. No requirement for src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen
4. The proto-oncogene c-Cbl is a negative regulator of DNA synthesis initiated by both receptor and cytoplasmic tyrosine kinases
5. Signal-transduction cascades as targets for therapeutic intervention by natural products
6. Activation of Src family members is not required for the platelet-derived growth factor beta receptor to initiate mitogenesis
7. Protein kinase C in the treatment of disease: Signal transduction pathways, inhibitors, and agents in development
8. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation
9. Signal transduction via platelet-derived growth factor receptors
10. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein
11. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase
12. Src family kinases are required for integrin but not PDGFR signal transduction
13. Rapid and efficient purification of Src homology 2 domain-containing proteins: Fyn, Csk and phosphatidylinositol 3-kinase p85
14. Association between the PDGF receptor and members of the src family of tyrosine kinases
15. Inhibitors of serine/threonine kinases
16. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1
17. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation
18. Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases
19. Electroporation of pp60c-src antibodies inhibits the angiotensin II activation of phospholipase C-gamma 1 in rat aortic smooth muscle cells
20. Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases
21. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity
22. Opposite effects of the overexpression of protein kinase C gamma and delta on the growth properties of human glioma cell line U251 MG
23. Inhibition of protein kinase C - Do we, can we, and should we?
24. DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases
25. Requirement of phospholipase Cγ, the tyrosine phosphatase Syp and the adaptor proteins Shc and Nck for PDGF-induced DNA synthesis: Evidence for the existence of Ras-dependent and Ras-independent pathways
26. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins
27. Tyrosine residues 239 and 240 of Shc are phosphatidylinositol 4,5-bisphosphate-dependent phosphorylation sites by c-Src
28. Phosphatidylinositol 4,5-bisphosphate stimulates phosphorylation of the adaptor protein Shc by c-Src
29. Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl) methylindenyl] indolin-2-ones as inhibitors of VEGF, PDGF, and FGF receptor tyrosine kinases
30. Synthesis and biological evaluations of 3-substituted indolin-2-ones: A novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases
31. The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells
32. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions
33. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling
34. Activation of protein serine/threonine kinases p42, p63, and p87 in Rous sarcoma virus-transformed cells: Signal transduction/transformation-dependent MBP kinases
35. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies